Invesco Ltd. Prothena Corp Public LTD CO Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Invesco Ltd. holds 41,214 shares of PRTA stock, worth $594,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,214

Previous 41,103 0.27%

Holding current value

$594,718

Previous $848,000 18.75%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$16.73 - $24.79 $1,857 - $2,751	111 Added 0.27%	41,214 $689,000
Q2 2024 Aug 13, 2024	BUY	$19.54 - $26.15 $11,704 - $15,663	599 Added 1.48%	41,103 $848,000
Q1 2024 May 14, 2024	BUY	$24.75 - $40.66 $343,752 - $564,726	13,889 Added 52.18%	40,504 $1 Million
Q4 2023 Feb 12, 2024	SELL	$32.31 - $52.32 $132,535 - $214,616	-4,102 Reduced 13.35%	26,615 $967,000
Q3 2023 Nov 13, 2023	SELL	$47.3 - $70.6 $1.57 Million - $2.35 Million	-33,228 Reduced 51.96%	30,717 $1.48 Million
Q2 2023 Aug 11, 2023	BUY	$48.26 - $78.59 $1.72 Million - $2.8 Million	35,593 Added 125.54%	63,945 $4.37 Million
Q1 2023 May 12, 2023	SELL	$46.97 - $58.27 $655,325 - $812,983	-13,952 Reduced 32.98%	28,352 $1.37 Million
Q4 2022 Feb 13, 2023	BUY	$52.05 - $65.0 $1.29 Million - $1.61 Million	24,822 Added 141.99%	42,304 $2.55 Million
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $5.68 Million - $13.7 Million	-225,871 Reduced 92.82%	17,482 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$22.73 - $39.98 $1.18 Million - $2.08 Million	52,130 Added 27.26%	243,353 $6.61 Million
Q1 2022 May 16, 2022	BUY	$30.27 - $49.22 $1.01 Million - $1.64 Million	33,403 Added 21.17%	191,223 $6.99 Million
Q4 2021 Feb 14, 2022	SELL	$42.11 - $73.26 $7.98 Million - $13.9 Million	-189,604 Reduced 54.57%	157,820 $7.8 Million
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $2.49 Million - $4.07 Million	51,565 Added 17.43%	347,424 $24.7 Million
Q2 2021 Aug 17, 2021	BUY	$21.63 - $57.65 $1.46 Million - $3.9 Million	67,574 Added 29.6%	295,859 $15.2 Million
Q1 2021 May 17, 2021	BUY	$11.0 - $28.24 $2.17 Million - $5.58 Million	197,641 Added 644.96%	228,285 $5.74 Million
Q4 2020 Feb 16, 2021	SELL	$10.12 - $13.94 $23,093 - $31,811	-2,282 Reduced 6.93%	30,644 $368,000
Q3 2020 Nov 16, 2020	SELL	$9.93 - $13.47 $17,635 - $23,922	-1,776 Reduced 5.12%	32,926 $329,000
Q2 2020 Aug 14, 2020	BUY	$9.56 - $12.51 $41,031 - $53,692	4,292 Added 14.11%	34,702 $363,000
Q1 2020 May 15, 2020	SELL	$7.54 - $15.77 $22,295 - $46,631	-2,957 Reduced 8.86%	30,410 $325,000
Q4 2019 Feb 14, 2020	SELL	$7.48 - $17.01 $16,560 - $37,660	-2,214 Reduced 6.22%	33,367 $528,000
Q3 2019 Nov 14, 2019	SELL	$6.89 - $10.45 $9,515 - $14,431	-1,381 Reduced 3.74%	35,581 $279,000
Q2 2019 Aug 14, 2019	SELL	$8.85 - $12.49 $224,480 - $316,808	-25,365 Reduced 40.7%	36,962 $391,000
Q1 2019 May 15, 2019	BUY	$10.32 - $14.49 $247,463 - $347,455	23,979 Added 62.53%	62,327 $756,000
Q4 2018 Feb 14, 2019	BUY	$8.73 - $13.74 $334,778 - $526,901	38,348 New	38,348 $395,000

Others Institutions Holding PRTA

# of Institutions

186

Shares Held

42.8M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $677M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account